Achieving Quality and Effectiveness in Dementia Using Crisis Teams (AQUEDUCT): a study protocol for a randomised controlled trial of a Resource Kit.


Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
18 Jan 2022
Historique:
received: 24 06 2021
accepted: 30 12 2021
entrez: 19 1 2022
pubmed: 20 1 2022
medline: 21 1 2022
Statut: epublish

Résumé

Improving care at home for people with dementia is a core policy goal in the dementia strategies of many European countries. A challenge to effective home support is the occurrence of crises in the care of people with dementia which arise from changes in their health and social circumstances. Improving the management of these crises may prevent hospital admissions and facilitate better and longer care at home. This trial is part of a National Institute for Health Research funded programme, AQUEDUCT, which aims to improve the quality and effectiveness of teams working to manage crises in dementia. It is a pragmatic randomised controlled trial of an online Resource Kit to enhance practice in teams managing crises in dementia care. Thirty teams managing mental health crises in dementia in community settings will be randomised between the Resource Kit intervention and treatment as usual. The primary outcome measure is psychiatric admissions to hospital for people with dementia in the teams' catchment area recorded 6 months after randomisation. Other outcomes include quality of life measures for people with dementia and their carers, practitioner impact measures, acute hospital admissions and costs. To enhance understanding of the Resource Kit intervention, qualitative work will explore staff, patient and carers' experience. The Resource Kit intervention reflects current policy to enable home-based care for people with dementia by addressing the management of crises which threaten the viability of care at home. It is based upon a model of best practice for managing crises in dementia designed to enhance the quality of care, developed in partnership with people with dementia, carers and practitioners. If the Resource Kit is shown to be clinically and cost-effective in this study, this will enhance the probability of its incorporation into mainstream practice. ISRCTN 42855694 ; Registered on 04/03/2021; Protocol number: 127686/2020v9; Research Ethics Committee, 09/03/2021, Ref 21/WM/0004; IRAS ID: 289982.

Sections du résumé

BACKGROUND BACKGROUND
Improving care at home for people with dementia is a core policy goal in the dementia strategies of many European countries. A challenge to effective home support is the occurrence of crises in the care of people with dementia which arise from changes in their health and social circumstances. Improving the management of these crises may prevent hospital admissions and facilitate better and longer care at home. This trial is part of a National Institute for Health Research funded programme, AQUEDUCT, which aims to improve the quality and effectiveness of teams working to manage crises in dementia.
METHODS/DESIGN METHODS
It is a pragmatic randomised controlled trial of an online Resource Kit to enhance practice in teams managing crises in dementia care. Thirty teams managing mental health crises in dementia in community settings will be randomised between the Resource Kit intervention and treatment as usual. The primary outcome measure is psychiatric admissions to hospital for people with dementia in the teams' catchment area recorded 6 months after randomisation. Other outcomes include quality of life measures for people with dementia and their carers, practitioner impact measures, acute hospital admissions and costs. To enhance understanding of the Resource Kit intervention, qualitative work will explore staff, patient and carers' experience.
DISCUSSION CONCLUSIONS
The Resource Kit intervention reflects current policy to enable home-based care for people with dementia by addressing the management of crises which threaten the viability of care at home. It is based upon a model of best practice for managing crises in dementia designed to enhance the quality of care, developed in partnership with people with dementia, carers and practitioners. If the Resource Kit is shown to be clinically and cost-effective in this study, this will enhance the probability of its incorporation into mainstream practice.
TRIAL REGISTRATION BACKGROUND
ISRCTN 42855694 ; Registered on 04/03/2021; Protocol number: 127686/2020v9; Research Ethics Committee, 09/03/2021, Ref 21/WM/0004; IRAS ID: 289982.

Identifiants

pubmed: 35042544
doi: 10.1186/s13063-021-05995-y
pii: 10.1186/s13063-021-05995-y
pmc: PMC8764492
doi:

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

54

Subventions

Organisme : programme grants for applied research
ID : RP-PG-0612-20004

Informations de copyright

© 2022. The Author(s).

Références

J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Aging Ment Health. 2013;17(3):328-35
pubmed: 23153294
Qual Life Res. 2013 Sep;22(7):1717-27
pubmed: 23184421
Health Econ. 1993 Dec;2(4):313-22
pubmed: 8142993
Clin Interv Aging. 2017 Oct 03;12:1589-1603
pubmed: 29042760
BMJ. 2001 Nov 10;323(7321):1123-4
pubmed: 11701584
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Int J Geriatr Psychiatry. 2011 Dec;26(12):1221-30
pubmed: 21351154
PLoS One. 2020 May 5;15(5):e0232076
pubmed: 32369511
JMIR Res Protoc. 2020 Oct 13;9(10):e18971
pubmed: 33048059
BMJ. 2005 Sep 17;331(7517):599
pubmed: 16103032
BMJ. 2013 Jan 08;346:e7586
pubmed: 23303884
Eval Program Plann. 1982;5(3):233-7
pubmed: 10259963
Br J Psychiatry. 2006 Nov;189:441-5
pubmed: 17077435
BMC Psychiatry. 2020 Oct 13;20(1):505
pubmed: 33050901
Br J Psychiatry. 2005 Jul;187:68-75
pubmed: 15994574
Int J Geriatr Psychiatry. 2007 Mar;22(3):263-5
pubmed: 17311360
JMIR Res Protoc. 2021 Jan 27;10(1):e14781
pubmed: 33502333
BMC Psychiatry. 2015 Apr 08;15:74
pubmed: 25879674

Auteurs

Donna Maria Coleston-Shields (DM)

Mental Health & Clinical Neurosciences, University of Nottingham, Nottingham, UK.

David Challis (D)

Mental Health & Clinical Neurosciences, University of Nottingham, Nottingham, UK. david.challis@nottingham.ac.uk.

Angela Worden (A)

Mental Health & Clinical Neurosciences, University of Nottingham, Nottingham, UK.

Emma Broome (E)

NIHR Nottingham Biomedical Research Centre, Hearing Sciences, University of Nottingham, Nottingham, UK.

Tom Dening (T)

Mental Health & Clinical Neurosciences, University of Nottingham, Nottingham, UK.

Boliang Guo (B)

School of Medicine, University of Nottingham, Nottingham, UK.

Juanita Hoe (J)

School of Health Sciences, City, University of London, London, UK.

Brynmor Lloyd-Evans (B)

Division of Psychiatry, University College London, London, UK.

Esme Moniz-Cook (E)

Faculty of Health Sciences, University of Hull, Hull, UK.

Steve Morris (S)

Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Fiona Poland (F)

School of Health Sciences, University of East Anglia, Norwich, UK.

David Prothero (D)

Institute of Mental Health, University of Nottingham, Nottingham, UK.

Martin Orrell (M)

Mental Health & Clinical Neurosciences, University of Nottingham, Nottingham, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH